Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Cufer, Tanja*" or (type exact bookEditor and editor="Cufer, Tanja*")

Add to list
European Groundshot addressing Europe's cancer research challenges : a Lancet Oncology Commission

Mark Lawler, Lynne Davies, Simon Oberst, Kathy Oliver, Alexander Eggermont, Anna Schmutz, Carlo La Vecchia, Claudia Allemani, Yolande Lievens (UGent) , Peter Naredi, et al.

(2023) LANCET ONCOLOGY. 24(1). p.E11-E56
Add to list
Definition of synchronous oligometastatic non–small cell lung cancer : a consensus report

Anne-Marie C. Dingemans, Lizza E.L. Hendriks, Thierry Berghmans, Antonin Levy, Baktiar Hasan, Corinne Faivre-Finn, Matteo Giaj-Levra, Niccolò Giaj-Levra, Nicolas Girard, Laurent Greillier, et al.

(2019) JOURNAL OF THORACIC ONCOLOGY. 14(12). p.2109-2119
Add to list
- Miscellaneous
Moonshot or groundshot : addressing Europe's cancer challenge through a patient-focused, data-enabled lens

Mark Lawler, Peter Naredi, Tanja Cufer, Ian Banks, Yolande Lievens (UGent) , Giles Vassal, Matti Aapro, Maja Južnič Sotlar, Thierry Philip, Jacek Jassem, et al.

(2019) LANCET ONCOLOGY. 20(11). p.1482-1485
Add to list
Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)

Mary ER O'Brien, Rabab Gaafar, Baktiar Hasan, Jessica Menis, Tanja Cufer, Sanjay Popat, Penella J Woll, Veerle Surmont (UGent) , Vassilis Georgoulias, Ana Montes, et al.

(2015) EUROPEAN JOURNAL OF CANCER. 51(12). p.1511-1528
Add to list
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)

Mary ER O'Brien, Rabab M Gaafar, Sanjay Popat, Francesco Grossi, Allan Price, Denis C Talbot, Tanja Cufer, Christian Ottensmeier, Sarah Danson, Athanasios Pallis, et al.

(2013) EUROPEAN JOURNAL OF CANCER. 49(13). p.2815-2822

Academic Bibliography

European Groundshot addressing Europe's cancer research challenges : a Lancet Oncology Commission

Definition of synchronous oligometastatic non–small cell lung cancer : a consensus report

Moonshot or groundshot : addressing Europe's cancer challenge through a patient-focused, data-enabled lens

Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)

Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)

Contents

Support

Contact